Catalyst Wire Dossier Catalyst Wire Dossier

Shigella vaccine CVD 30000

· University of Maryland, Baltimore
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Shigella vaccine CVD 30000, covering 2024-05-20 to 2024-05-20. Get the full timeline:

Most recent: Clinical Trial Update: Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine [Phase 2]

See pricing